Two cancer research studies demonstrate use of RNA sequencing for precision oncology

November 24, 2021 Leave a comment 1,373 Views

Genetron Health announced the release of two research results from its Seq-MRD® and FusionScan Plus product studies at the Association for Molecular Pathology 2021 annual meeting. Seq-MRD® detects minimal residual disease (MRD) in B-lymphoid malignancies, while FusionScan Plus can simultaneously detect a wide ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: FusionScan Plus

Two cancer research studies demonstrate use of RNA sequencing for precision oncology

BEETLE ATLAS – a definitive, tissue-specific transcriptomic resource based on RNA-Seq data for the Tribolium community

ElasticBLAST – accelerating sequence search via cloud computing

TileDB launches cross-language access to single-cell data

Researchers have developed an instrument-free single-cell RNA sequencing using a reversible hydrogel for cell-specific barcoding

Transcriptomic analysis of yeast paves way to more efficient production of 2G ethanol

Upcoming Webinar – RNA-Seq: Enhancing Single-Cell Data & Cell Recovery Rates for Complex Tissue Samples

A dual-purpose polymerase engineered for direct sequencing of pseudouridine and queuosine RNA modifications